Concept information
Terme préférentiel
Anti-Arrhythmia Agents
Type
-
mesh:Descriptor
Définition
- Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
Concept générique
Synonyme(s)
- Anti-Arrhythmia Agent
- Antiarrhythmia Agent
- Antiarrhythmia Agents
- Anti-Arrhythmia Drug
- Antiarrhythmia Drug
- Anti-Arrhythmia Drugs
- Antiarrhythmia Drugs
- Anti-Arrhythmic
- Antiarrhythmic Drug
- Antiarrhythmic Drugs
- Anti-Arrhythmics
Qualificatif(s) autorisé(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- analysis (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Traductions
-
français
-
Agents antiarythmiques
-
Anti-arythmiques
-
Antiarythmisants
-
Médicaments antiarythmiques
URI
http://data.loterre.fr/ark:/67375/JVR-LS0SSBHQ-R
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}